Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Nafine Group International is a Chinese industrial company that was primarily engaged in the production and sale of inorganic salt products and consumer chemicals. The company was one of the world's largest producers of sodium sulfate, a key ingredient in detergents, glassmaking, and certain pharmaceutical processes. Its operations were centered in Shanxi Province, China, where it also manufactured sodium sulfide, barium sulfate, and household cleaning products under the Nafine brand. While the company's products supported various industrial and medical applications, it was not a drug development or biotechnology firm. The US-listed entity (CNFG) was eventually delisted, and its primary Chinese assets were involved in a significant corporate restructuring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Nafine Group International.